THOMAS DYRBERG

Profile

First Name

: THOMAS

Middle Name

:

Last Name

: DYRBERG

Related Companies
Titles
Company Name
Related People
DIRECTOR
LUX BIOSCIENCES INC
EDDY ANGLADE, A. CLARKE ATWELL, AXEL BOLTE, PAUL CHANEY, PAUL G. CHANEY, GEORGE ELDRIDGE, LUTZ GIEBEL, ULRICH M. GRAU, DAVID GUYER, DEAN MITCHELL, DEAN J MITCHELL, DAVID SCHNELL, BRETT SKOLNIK
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC
ALAN B. COLOWICK, SETH HARRISON, DONALD J. HAYDEN, JAY MOORIN, JEAN C. NICHOLS, DAVID SCHNELL, MARTIN VOGELBAUM, NICHOLAS VROLIJK
DIRECTOR
OPHTHOTECH CORP.
THOMAS BIANCARDI, ALEX BOLTE, AXEL BOLTE, DAVID CARROLL, NICHOLAS GALAKATOS, LUTZ GIEBEL, DAVID GUYER, EVELYN HARRISON, JANE PRITCHETT HENDERSON, SAMIR C. PATEL, BRUCE PEACOCK, DAVID REDLICK, MICHAEL ROSS, GLENN SBLENDORIO, HENRY SIMON, KEITH WESTBY
DIRECTOR
ALLOCURE INC
METTE KIRSTINE AGGER, ROBERT M BRENNER, ROBERT M. BRENNER, SCOTT CANUTE, THOMAS DRYBERG, GEORGE ELDRIDGE, LUTZ GIEBEL, DAVID GUYER, KEVIN J. HEYECK, CHRISTOF WESTENFELDER, JOHN WIRTHLIN, JOHN B. WIRTHLIN
DIRECTOR
PANOPTICA, INC.
ABBIE CELNIKER, PAUL CHANEY, LUTZ GIEBEL, COLIN GODDARD, DAVID GUYER, GIEBEL LUTZ, BRUCE PEACOCK, TRACY SAXTON, KEVIN STARR
DIRECTOR
GALERA THERAPEUTICS, INC.
LAWRENCE ALLEVA, JAMES BARRETT, ROBERT BEARDSLEY, ROBERT A. BEARDSLEY, ROBERT J. CALCATERRA, NANCY T. CHANG, ARTHUR FRATAMICO, MICHAEL R. FRIEDMAN, ERIC GULVE, JON T. HOLMLUND, JEFFERY L. KEENE, KEVIN LOKAY, CAMPBELL MURRAY, MICHAEL POWELL, DENNIS P. RILEY, STEPHEN ROSS, MICHAL SILVERBERG, HENRY SKINNER, J. MEL SORENSEN, MEL SORENSEN, JOEL SUSSMAN, FRANK TORTI
DIRECTOR
PRAXIS PRECISION MEDICINES, INC.
ARI BRETTMAN, STUART CHAFFEE, NICHOLAS GALAKATOS, NICHOLAS G. GALAKATOS, PAUL MEDEIROS, GREGORY NORDEN, KIRAN REDDY, ALFRED SANDROCK, ALFRED SANDROCK, JR., STEFAN VITOROVIC, WILLIAM YOUNG, WILLIAM D. YOUNG
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-06-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-18 
2018-11-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-10-30 
2018-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-30 
2016-11-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-15 
2016-05-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-10 
2013-12-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-29 
2013-06-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-23 
2013-03-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2013-03-15 
2013-01-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2012-12-24 
2012-07-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2012-06-20 
2012-04-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-29 
2012-03-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-23 
2011-12-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-12-05 
2011-10-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-09-30 
2011-07-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-06-30 
2011-03-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-03-03 
2010-12-20
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2010-12-03 
2009-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-11 
2009-10-30
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-10-15 
2009-10-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-14 
2009-08-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-14 
2009-06-16
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2009-06-03